Results 241 to 250 of about 201,939 (281)
ABSTRACT Aim The COSGOD III trial was designed to guide oxygen delivery by cerebral near infrared spectroscopy (NIRS) in preterm neonates during the immediate transition after birth and showed a non‐significant increase of 4.3% in survival without cerebral injury compared to the control group.
Christina Schreiner+9 more
wiley +1 more source
Surviving Extremely Low Birth Weight Infants Have a Higher Risk of ROP in Sub‐Saharan Africa
ABSTRACT Aim Retinopathy of prematurity (ROP) risk factors have been investigated in population‐based studies from most global regions. No such studies are available from Sub‐Saharan Africa (SSA), where improved neonatal care is increasing the survival of preterm infants at risk of ROP.
Tshilidzi van der Lecq+6 more
wiley +1 more source
Development and Content of Core Outcome Sets in Neonatology—A Scoping Review
ABSTRACT Aim To identify subgroups of neonates for whom core outcome sets (COS) have been developed, the outcomes that were included and the methods used in their formulation. Methods We performed a scoping review and searched databases in April 2025 for published COS.
Ilari Kuitunen+3 more
wiley +1 more source
ABSTRACT Aim This study evaluated urinary calcium (Ca) and phosphorus (P) excretion in very low birth weight infants ( < 1500 g, VLBW) without severe morbidity, treated with methylxanthines. Methods Eighty‐one VLBW infants were analysed. Urinary Ca and P and their creatinine ratios were measured biweekly until day 56.
Tomas Matejek+5 more
wiley +1 more source
ABSTRACT Aim Human milk‐based fortifiers (HMBFs) have been adopted in neonatal care despite limited efficacy data. Our objective was to conduct a Bayesian re‐analysis of the current evidence on the protective effect of HMBF against necrotising enterocolitis (NEC, stage II‐III).
Maurice J. Huizing+5 more
wiley +1 more source
Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases
Neurodegenerative disorders are characterised by the chronic progressive degeneration of specific neuronal subtypes, neuroinflammation, myelin damage and synaptic loss. Despite their growing incidence, advancements in effective treatments remain limited, because of lack of knowledge for the aetiology of the diverse pathophysiology to design systematic ...
Ioanna Zota+4 more
wiley +1 more source
Proposal for a Germline Expert Panel to Improve Variant Reclassification in Japan
This letter argues that Japan's dependence on a single foreign company for classifying germline variants is delaying critical treatment for cancer patients. The author proposes establishing a national “Germline Expert Panel” to provide independent, timely oversight, and ensure patients receive appropriate care.
Kazuki Yamazawa
wiley +1 more source
ABSTRACT Context Familial partial lipodystrophy type 2 (FPLD2) is a rare autosomal dominant disorder caused by pathogenic variants in the LMNA gene. The influence of parental inheritance on clinical presentation has not been fully explored. Objective To investigate the influence of maternal versus paternal inheritance of LMNA variants on the clinical ...
Donatella Gilio+12 more
wiley +1 more source
ABSTRACT Background This study examines the long‐term effectiveness of anti‐VEGF therapy in managing neovascular age‐related macular degeneration (nAMD). Despite the well‐established short‐term improvements of anti‐VEGF therapy, there is limited data on its continued efficacy over extended periods.
Kimberly Spooner+5 more
wiley +1 more source
ABSTRACT Background Artificial intelligence (AI) enhanced retinal screening could reduce the impact of diabetic retinopathy (DR), the leading cause of preventable blindness in Australia. This study assessed the performance and validity of a dual‐modality, deep learning system for detection of vision‐threatening diabetic retinopathy (vtDR) in a multi ...
Jason R. Daley+12 more
wiley +1 more source